Coral Laboratories [CORALAB] vs Innova Captab [INNOVACAP] Detailed Stock Comparison

Coral Laboratories Ltd.

BSE
Loading...

Innova Captab Ltd.

NSE
Loading...

TLDR: Quick Comparison Summary

Based on 20 vital metrics comparison: Coral Laboratories Ltd. wins in 11 metrics, Innova Captab Ltd. wins in 9 metrics, with 0 ties. Coral Laboratories Ltd. appears stronger overall.

View Metrics Details

Vital Metrics Comparison

Metric Coral Laboratories Ltd. Innova Captab Ltd. Better
P/E Ratio (TTM) 11.06 31.20 Coral Laboratories Ltd.
Price-to-Book Ratio 0.73 4.05 Coral Laboratories Ltd.
Debt-to-Equity Ratio 0.41 32.95 Coral Laboratories Ltd.
PEG Ratio -0.20 1.33 Innova Captab Ltd.
EV/EBITDA 4.44 20.49 Coral Laboratories Ltd.
Profit Margin (TTM) 15.97% 8.85% Coral Laboratories Ltd.
Operating Margin (TTM) 5.58% 12.88% Innova Captab Ltd.
EBITDA Margin (TTM) 5.58% 12.88% Innova Captab Ltd.
Return on Equity 12.01% 13.37% Innova Captab Ltd.
Return on Assets (TTM) 10.53% 8.12% Coral Laboratories Ltd.
Free Cash Flow (TTM) $-41.67M $-1.09B Coral Laboratories Ltd.
Dividend Yield 0.29% 0.30% Innova Captab Ltd.
1-Year Return -18.38% 3.87% Innova Captab Ltd.
Price-to-Sales Ratio (TTM) 1.77 2.76 Coral Laboratories Ltd.
Enterprise Value $532.28M $43.41B Innova Captab Ltd.
EV/Revenue Ratio 0.61 2.90 Coral Laboratories Ltd.
Gross Profit Margin (TTM) 59.74% 35.19% Coral Laboratories Ltd.
Revenue per Share (TTM) $245 $262 Innova Captab Ltd.
Earnings per Share (Diluted) $39.14 $23.16 Coral Laboratories Ltd.
Beta (Stock Volatility) 0.90 -0.33 Innova Captab Ltd.

Coral Laboratories Ltd. vs Innova Captab Ltd. Stock Performance Analysis

Loading Price Chart...

CORALAB
INNOVACAP

Performance Comparison

Short-term Returns

Stock1D1W1M3M6MYTD
Coral Laboratories Ltd.2.22%0.75%9.98%18.09%9.54%13.35%
Innova Captab Ltd.0.58%8.95%10.45%34.08%34.58%28.37%

Long-term Returns

Stock1Y3Y5Y10Y15Y20Y
Coral Laboratories Ltd.-18.38%101.77%4.69%9.89%526.74%564.59%
Innova Captab Ltd.3.87%74.08%74.08%74.08%74.08%74.08%

Performance & Financial Health Analysis: Coral Laboratories Ltd. vs Innova Captab Ltd.

MetricCORALABINNOVACAP
Market Information
Market Cap i₹1.53B₹41.43B
Market Cap CategorySmall capSmall cap
10 Day Avg. Volume i1,566578,151
90 Day Avg. Volume i2,815217,693
Last Close₹500.65₹947.95
52 Week Range₹360.00 - ₹624.95₹622.00 - ₹978.00
% from 52W High-19.89%-3.07%
All-Time High₹1,190.00 (Jul 24, 2017)₹1,260.00 (Jan 06, 2025)
% from All-Time High-57.93%-24.77%
Growth Metrics
Quarterly Revenue Growth-0.06%0.42%
Quarterly Earnings Growth-0.55%0.23%
Financial Health
Profit Margin (TTM) i0.16%0.09%
Operating Margin (TTM) i0.06%0.13%
Return on Equity (TTM) i0.12%0.13%
Debt to Equity (MRQ) i0.4132.95
Cash & Liquidity
Book Value per Share (MRQ)₹596.42₹178.28
Cash per Share (MRQ)₹286.45₹10.22
Operating Cash Flow (TTM) i₹106.44M₹282.88M
Levered Free Cash Flow (TTM) i₹241.56M₹1.28B
Dividends
Last 12-Month Dividend Yield i0.29%0.30%
Last 12-Month Dividend i₹1.50₹2.00

Valuation & Enterprise Metrics Analysis: Coral Laboratories Ltd. vs Innova Captab Ltd.

MetricCORALAB (Apr 24, 2026)INNOVACAP (Apr 24, 2026)
Price Ratios
P/E Ratio (TTM) i11.0631.20
Forward P/E i7.4521.90
PEG Ratio i-0.201.33
Price to Sales (TTM) i1.772.76
Price to Book (MRQ) i0.734.05
Market Capitalization
Market Capitalization i₹1.53B₹41.43B
Enterprise Value i₹532.28M₹43.41B
Enterprise Value Metrics
Enterprise to Revenue i0.612.90
Enterprise to EBITDA i4.4420.49
Risk & Other Metrics
Beta i0.90-0.33
Book Value per Share (MRQ) i₹596.42₹178.28

Financial Statements Comparison: Coral Laboratories Ltd. vs Innova Captab Ltd.

Financial Metrics

Loading Financial Charts...

Revenue

Operating Margin

Profit Margin

Long Term Debt

Income Flow Analysis

Financial Statements Comparison

Income Statement

MetricCORALAB (2025)INNOVACAP (2025)
Revenue/Sales i1.13B12.34B
Cost of Goods Sold i561.92M8.38B
COGS % of Revenue i49.6%67.9%
Gross Profit i569.87M3.96B
Gross Margin i50.4%32.1%
Research & Development iN/AN/A
Operating Income (EBIT) i246.11M1.65B
Operating Margin i21.7%13.4%
EBITDA i353.48M2.00B
EBITDA Margin i31.2%16.2%
Pre-Tax Income i324.70M1.71B
Pre-Tax Income % of Revenue i28.7%13.9%
Income Tax i83.15M427.58M
Income Tax % of Revenue i7.3%3.5%
Net Income (Profit) i241.56M1.28B
Profit Margin i21.3%10.4%

Balance Sheet & Liquidity Metrics

MetricCORALAB (2025)INNOVACAP (2025)
Cash & Equivalents i34.06M155.19M
Total Current Assets i1.77B7.03B
Total Current Assets % of Revenue i156.0%57.0%
Total Current Liabilities i249.58M3.53B
Total Current Liabilities % of Revenue i22.1%28.6%
Long-Term Debt i02.45B
Long-Term Debt % of Revenue i0.0%19.8%
Total Shareholders Equity i2.01B9.59B
Retained Earnings i1.71B4.53B
Retained Earnings % of Revenue i151.0%36.7%
Property, Plant & Equipment i217.44M442.93M

Cash Flow Statement Comparison

MetricCORALAB (2025)INNOVACAP (2025)
Operating Cash Flow i106.44M282.88M
Operating Cash Flow % of Revenue i9.4%2.3%
Capital Expenditures i-29.45M-1.72B
Free Cash Flow i-41.67M-1.09B
FCF Margin i-3.7%-8.8%
Debt Repayment iN/A-114.03M
Common Stock Repurchase iN/AN/A

Short Interest & Institutional Ownership Analysis

MetricCORALABINNOVACAP
Shares Short iN/AN/A
Short Ratio iN/AN/A
Short % of Float iN/AN/A
Shares Outstanding i3.57M57.22M
Float Shares i802,60915.91M
% Held by Insiders i78.86%72.19%
% Held by Institutions i0.00%19.22%
% Held by Public i21.14%8.59%

Dividend Analysis & Yield Comparison: Coral Laboratories Ltd. vs Innova Captab Ltd.

MetricCORALABINNOVACAP
Last 12-Month Dividend i₹1.50₹2.00
Last 12-Month Dividend Yield i0.29%0.30%
3-Year Avg Annual Dividend i₹1.17₹0.67
3-Year Avg Dividend Yield i0.26%0.30%
3-Year Total Dividends i₹3.50₹2.00
Ex-Dividend DateSep 19, 2025Jan 30, 2026